Cost–utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B
<p><strong>Objective</strong></p> <p>The aim of this study was to assess the cost-effectiveness of tenofovir disoproxil fumarate (TDF) in the treatment of chronic hepatitis B (CHB) versus alternative nucleos(t)ides from a UK National Health Service (NHS) perspective.<...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2011
|